HealthcareServices

Liver Cirrhosis Market Outlook: Growth and Forecast Highlights 2030

February 26, 2026February 26, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the liver cirrhosis market from 2026–2035 with trusted insights from The Business Research Company

How much is the Liver Cirrhosis Market valued at in 2026, and what valuation is forecast for 2030?

The liver cirrhosis market size has observed substantial growth in recent years. It is anticipated to increase from $1.99 billion in 2025 to $2.15 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. The expansion during the historic period can be attributed to consistent alcohol consumption patterns, widespread hepatitis B and C infections, insufficient early detection of liver damage, a rising occurrence of fatty liver disease, and a historical absence of curative treatment options.

The liver cirrhosis market is anticipated to undergo significant expansion in the upcoming years. It is projected to attain a value of $2.88 billion by 2030, progressing at a compound annual growth rate (CAGR) of 7.7%. This growth over the forecast period is propelled by factors such as the increasing burden of NASH and metabolic syndrome, growing awareness of liver health, expanding access to diagnostic testing, rising demand for advanced liver care, and increased healthcare spending on chronic diseases. Prominent trends within the forecast period encompass the rising prevalence of chronic liver diseases, a growing focus on early diagnosis and disease monitoring, increasing demand for long-term disease management, the expansion of supportive and symptom-based therapies, and a rising need for specialized hepatology care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

What Drivers Are Influencing The Growth Of The Liver Cirrhosis Market?

The liver cirrhosis market is anticipated to expand due to a rise in alcohol consumption. This consumption is defined as the intake of alcoholic drinks, generally quantified by volume and regularity. Individuals are progressively consuming alcohol as it aids in unwinding from daily pressures, strengthening social bonds at gatherings, and elevating periods of relaxation, in addition to being extensively promoted through various media channels and becoming more accessible in diverse environments. Treating liver cirrhosis in patients with excessive alcohol intake primarily involves managing liver damage through sobriety, pharmaceutical interventions, and supportive medical attention, concurrently addressing alcohol dependence with professional counseling and rehabilitation programs. For example, the US-based government agency, Bureau of Labor Statistics, reported in December 2024, that in 2023, U.S. households expended an average of $294 on alcoholic beverages consumed within the home and $343 on those consumed away from home. Consequently, the heightened consumption of alcohol serves as a key driver for the liver cirrhosis market.

How Is The Liver Cirrhosis Market Organized Into Various Segments?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegments:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

3) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

4) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

What Trends Are Driving The Growth Trajectory Of The Liver Cirrhosis Market?

Key players within the liver cirrhosis market are prioritizing advancements in therapeutic options, including the development of active implantable medical devices, to enhance patient well-being and expand treatment possibilities. Active implantable medical devices are electronically powered implants crafted to monitor, support, or improve organ function internally. As an illustration, in December 2024, Sequana Medical NV, a medical device company based in Belgium, secured U.S. FDA approval for its alfapump system, becoming the first active implantable medical device in the U.S. for handling recurrent or refractory ascites caused by liver cirrhosis. This groundbreaking technology provides an automated, continuous solution for fluid management by moving surplus abdominal fluid to the bladder, substantially reducing the need for invasive therapeutic paracentesis. The alfapump system represents a significant improvement in patient outcomes and quality of life, catering to an addressable market of approximately 70,000 patients in the United States.

Who Are The Major Companies Operating In The Liver Cirrhosis Market?

Major companies operating in the liver cirrhosis market are F Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd., Mindray Medical International Limited, Boston Scientific Corporation, Olympus Corporation, Echosens SA, Hologic Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Perspectum Diagnostics Ltd., Owlstone Medical Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Liver Cirrhosis Market?

North America was the largest region in the liver cirrhosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Liver Cirrhosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2026, By The Business Research Company

Hepatic Encephalopathy Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report

Liver Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report

Liver Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795